Why Is AstraZeneca's Stock Trading Higher Today?

AstraZeneca PLC AZN shares are trading higher after the company reported better-than-expected EPS and sales results.

AstraZeneca reported first-quarter adjusted earnings per share of $0.82, which beat analyst estimates of $0.75. The company also reported sales results of $7.32 billion, which beat analyst estimates of $7.08 billion.

AstraZeneca sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology.

AstraZeneca's stock was trading up 4% at $53.43 at the time of publication. The stock has a 52-week high of $64.94  and a 52-week low of $46.48.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!